|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.64 USD | -0.47% |
|
-9.16% | -13.00% |
| 11:37am | ANALYST RECOMMENDATIONS : Tesla, Snap, Alphabet, Microsoft, Anglo American... |  |
| 09:41am | Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion | RE |
Nov 6 (Reuters) - Bristol Myers Squibb has acquired Orum’s experimental therapy to treat patients with a type of blood cancer for a total value of up to $180 million, Orum said on Monday. (Reporting by Khushi Mandowara in Bengaluru; Editing by Dhanya Ann Thoppil)
| 1st Jan change | Capi. | |
|---|---|---|
| -13.00% | 90.49B | |
| +26.47% | 664B | |
| +24.85% | 567B | |
| -6.33% | 354B | |
| +19.35% | 330B | |
| +4.23% | 286B | |
| +13.94% | 234B | |
| +4.57% | 199B | |
| -9.98% | 196B | |
| -4.04% | 148B |
BRISTOL-MYERS SQUIBB COMPANY 
